Skip to main content
Andrew Feinberg, MD, Medical Genetics, Baltimore, MD

AndrewPaulFeinbergMD

Medical Genetics Baltimore, MD

Clinical Genetics

King Fahd Professor of Medicine, Oncology, Molecular Biology and Genetics, Professor of Medicine and Oncology, Johns Hopkins University School of Medicine; Chief, Division of Molecular Medicine, Department of Medicine; Director, Center for Epigenetics; Gilman Scholar, Johns Hopkins University

Dr. Feinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Feinberg's full profile

Already have an account?

  • Office

    855 N. Wolfe St.
    Rangos 570
    Baltimore, MD 21205
    Phone+1 410-614-3489

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1981 - 1982
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - Present
  • MD State Medical License
    MD State Medical License 1979 - 2026
  • MI State Medical License
    MI State Medical License 1986 - 1996
  • PA State Medical License
    PA State Medical License 1977 - 1990
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Clinical Genetics
    American Board of Medical Genetics and Genomics Clinical Genetics

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2007
  • Elected Member The American Society for Clinical Investigation, 1990
  • Investigator Alumnus Howard Hughes Medical Institute, 1986
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Article A Loss of Epigenetic Control Can Promote Cell Death Through Reversing the Balance of Pathways in a Signaling Network  
    Andrew Feinberg, MD, ScienceDirect

Press Mentions

  • Two Johns Hopkins Medicine Scientists Win Harvey Prize
    Two Johns Hopkins Medicine Scientists Win Harvey PrizeDecember 9th, 2024

Grant Support

  • Epigenetic drivers of cancer progressionJOHNS HOPKINS UNIVERSITY1991–2025
  • Epigenetic drivers of cancer progressionJOHNS HOPKINS UNIVERSITY1991–2025
  • Epigenetic drivers of cancer progressionJOHNS HOPKINS UNIVERSITY1991–2025
  • Epigenetic drivers of cancer progressionJOHNS HOPKINS UNIVERSITY1991–2025
  • A General Stochastic Epigenetic Model For Evolution, Development, And DiseaseOffice Of The Director, National Institutes Of Health2011
  • The Role And Genetic Mechanism Of Epigenetic Plasticity In Age-Related DiseaseNational Institute On Aging2011
  • Environment, The Perinatal Epigenome, And Risk For Autism And Related DisordersNational Institute Of Environmental Health Sciences2009–2011
  • 1/5: A Genome-Wide Methylation SCAN For Epigenetic Contributions To SchizophreniaNational Institute Of Mental Health2008–2011
  • Center For The Epigenetics Of Common Human DiseaseNational Human Genome Research Institute2004–2011
  • 1/5:Family-Based Genome-Wide Methylation SCAN In SchizophreniaNational Institute Of Mental Health2009–2010
  • Comparative Phenotypic, Functional, And Molecular Analysis Of ESC And IPSCNational Heart, Lung, And Blood Institute2009–2010
  • Genomic Imprinting In CancerNational Cancer Institute1994–2010
  • BWS And Embryonal Tumor Suppressor Genes On 11p15National Cancer Institute2001–2009
  • Functional AllelotypingNational Cancer Institute2007–2008
  • Minority Action PLANNational Human Genome Research Institute2004–2008
  • Center For The Epigenetics Of Common Human DiseasesNational Human Genome Research Institute2004–2008
  • Epigenetic Alterations In CMLNational Cancer Institute1998–2002
  • Genomic Imprinting In CMLNational Cancer Institute1996–1997
  • Identification Of The Earliest Steps In TransformationNational Cancer Institute1989–1993

Other Languages

  • French